Changes related to "Bendamustine"
This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
10 December 2018
| m 15:44 | Follicular lymphoma (diff | hist) . . (0) . . Jwarner (talk | contribs) |
| m 15:26 | Hodgkin lymphoma (2 changes | history) . . (+1,691) . . [Jwarner (2×)] | |
| m | 15:26 (cur | prev) . . (+1,112) . . Jwarner (talk | contribs) (→Flu-Mel, then allo HSCT {{#subobject:6f8499|Regimen=1}}) | |
| m | 13:06 (cur | prev) . . (+579) . . Jwarner (talk | contribs) (→MOPP {{#subobject:bcde0|Regimen=1}}) |
9 December 2018
| m 17:36 | Mantle cell lymphoma (diff | hist) . . (+1,134) . . Jwarner (talk | contribs) (→Observation) |
| m 12:04 | Chronic lymphocytic leukemia (CLL/SLL) (2 changes | history) . . (-4,549) . . [Jwarner (2×)] | |
| m | 12:04 (cur | prev) . . (+34) . . Jwarner (talk | contribs) (→FCR {{#subobject:b079e8|Regimen=1}}) | |
| m | 11:46 (cur | prev) . . (-4,583) . . Jwarner (talk | contribs) |
8 December 2018
| m 22:10 | Waldenström macroglobulinemia (diff | hist) . . (+1) . . Jwarner (talk | contribs) (→Supportive medications) |
7 December 2018
| m 13:54 | Cutaneous T-cell lymphoma (3 changes | history) . . (+391) . . [Jwarner (3×)] | |
| m | 13:54 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Vorinostat monotherapy {{#subobject:6a3a5b|Regimen=1}}) | |
| m | 13:52 (cur | prev) . . (+133) . . Jwarner (talk | contribs) (→Methotrexate monotherapy {{#subobject:0ff378|Regimen=1}}) | |
| m | 13:44 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→PUVA) |
| m 09:49 | Diffuse large B-cell lymphoma (9 changes | history) . . (+2,856) . . [Jwarner (9×)] | |
| m | 09:49 (cur | prev) . . (+279) . . Jwarner (talk | contribs) | |
| m | 09:48 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→Vinorelbine monotherapy {{#subobject:29c647|Regimen=1}}) | |
| m | 09:47 (cur | prev) . . (+676) . . Jwarner (talk | contribs) (→Rituximab monotherapy {{#subobject:d826ec|Regimen=1}}) | |
| m | 09:44 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Variant #1, 100 mg/m2 {{#subobject:1fc8c3|Variant=1}}) | |
| m | 09:43 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Ifosfamide monotherapy {{#subobject:b9a669|Regimen=1}}) | |
| m | 09:41 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→Variant #3, indefinite 3 out of 4 weeks {{#subobject:4d3a21|Variant=1}}) | |
| m | 09:40 (cur | prev) . . (+642) . . Jwarner (talk | contribs) (→Etoposide monotherapy {{#subobject:1ed00b|Regimen=1}}) | |
| m | 09:13 (cur | prev) . . (+135) . . Jwarner (talk | contribs) (→Variant #1, 750/300/800/800/140 {{#subobject:9131e1|Variant=1}}) | |
| m | 09:08 (cur | prev) . . (+608) . . Jwarner (talk | contribs) (→R-CHOEP-14 {{#subobject:75c24e|Regimen=1}}) |
6 December 2018
| m 23:19 | Hodgkin lymphoma (6 changes | history) . . (+2,282) . . [Warner-admin; Jwarner (5×)] | |
| m | 23:19 (cur | prev) . . (+673) . . Jwarner (talk | contribs) (→ChlVPP/EVA {{#subobject:8ee324|Regimen=1}}) | |
| m | 23:11 (cur | prev) . . (+693) . . Jwarner (talk | contribs) (→Observation) | |
| m | 22:58 (cur | prev) . . (+838) . . Jwarner (talk | contribs) | |
| m | 21:22 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Placebo) | |
| m | 20:18 (cur | prev) . . (+14) . . Jwarner (talk | contribs) (→References) | |
| m | 19:40 (cur | prev) . . (+64) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:50 | Diffuse large B-cell lymphoma (3 changes | history) . . (+1,825) . . [Warner-admin; Jwarner (2×)] | |
| m | 19:50 (cur | prev) . . (+11) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") | |
| m | 13:59 (cur | prev) . . (+1,467) . . Jwarner (talk | contribs) (→R-CHOP-14 {{#subobject:fc3bde|Regimen=1}}) | |
| m | 13:45 (cur | prev) . . (+347) . . Jwarner (talk | contribs) (→R-CHOP {{#subobject:240cc2|Regimen=1}}) |
| m 19:49 | Small cell lung cancer (diff | hist) . . (+8) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:47 | Marginal zone lymphoma (diff | hist) . . (+1) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:44 | Waldenström macroglobulinemia (diff | hist) . . (+4) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:43 | Chronic lymphocytic leukemia (CLL/SLL) (diff | hist) . . (+25) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:40 | Follicular lymphoma (diff | hist) . . (+3) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:34 | Mantle cell lymphoma (diff | hist) . . (+38) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:29 | Hairy cell leukemia (diff | hist) . . (+1) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
| m 19:26 | Peripheral T-cell lymphoma (diff | hist) . . (+1) . . Warner-admin (talk | contribs) (Text replacement - "http://www.nejm.org" to "https://www.nejm.org") |
5 December 2018
| m 23:18 | Follicular lymphoma (diff | hist) . . (+4,922) . . Jwarner (talk | contribs) |
| m 09:46 | Diffuse large B-cell lymphoma (2 changes | history) . . (+218) . . [Jwarner (2×)] | |
| m | 09:46 (cur | prev) . . (+9) . . Jwarner (talk | contribs) (→References) | |
| m | 09:43 (cur | prev) . . (+209) . . Jwarner (talk | contribs) (→Axicabtagene ciloleucel monotherapy {{#subobject:78231d|Regimen=1}}) |
| m 09:41 | Transformed lymphoma (diff | hist) . . (-528) . . Jwarner (talk | contribs) (→References) |
4 December 2018
| m 21:01 | Waldenström macroglobulinemia (diff | hist) . . (+562) . . Jwarner (talk | contribs) (→Everolimus monotherapy {{#subobject:f542c8|Regimen=1}}) |
| m 11:32 | Diffuse large B-cell lymphoma (diff | hist) . . (+555) . . Jwarner (talk | contribs) (→Brentuximab vedotin monotherapy {{#subobject:d4dff2|Regimen=1}}) |
| m 11:16 | Hodgkin lymphoma (2 changes | history) . . (-1,880) . . [Jwarner (2×)] | |
| m | 11:16 (cur | prev) . . (-1,512) . . Jwarner (talk | contribs) (→Sirolimus & Vorinostat {{#subobject:273a59|Regimen=1}}) | |
| m | 11:14 (cur | prev) . . (-368) . . Jwarner (talk | contribs) (→References) |
| m 10:14 | Follicular lymphoma (diff | hist) . . (+1,529) . . Jwarner (talk | contribs) (→R-FND {{#subobject:f8dffd|Regimen=1}}) |
3 December 2018
| m 22:21 | Mantle cell lymphoma (diff | hist) . . (+1,647) . . Jwarner (talk | contribs) |
| m 20:23 | Diffuse large B-cell lymphoma (2 changes | history) . . (+1,626) . . [Jwarner (2×)] | |
| m | 20:23 (cur | prev) . . (+603) . . Jwarner (talk | contribs) (→Ibrutinib monotherapy {{#subobject:ba5ba9|Regimen=1}}) | |
| m | 20:18 (cur | prev) . . (+1,023) . . Jwarner (talk | contribs) (→Observation) |
| m 19:06 | Follicular lymphoma (diff | hist) . . (+587) . . Jwarner (talk | contribs) (→References) |
| m 18:05 | Chronic lymphocytic leukemia (CLL/SLL) (diff | hist) . . (+754) . . Jwarner (talk | contribs) (→Ibrutinib monotherapy {{#subobject:8c370d|Regimen=1}}) |
